Screener
Eton Pharmaceuticals, Inc. ETON Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Long-term debt, net of current portion and debt discount | 18,939 | 21,769 |
| Operating lease liabilities, net of current portion | 440 | 460 |
| Other long-term liabilities | 3,537 | 5,241 |
| Total liabilities | 67,095 | 65,960 |
| Commitments and contingencies (Note 13) | ||
| Stockholders’ equity | ||
| Common stock, $0.001 par value; 50,000,000 shares authorized; 27,359,791 and 27,047,061 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 27 | 27 |
| Additional paid-in capital | 141,528 | 138,621 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s total liabilities?
- Eton Pharmaceuticals, Inc. (ETON) reported total liabilities of $67.1M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s total liabilities changed year-over-year?
- Eton Pharmaceuticals, Inc.'s total liabilities increased by 12.6% year-over-year, from $59.58M to $67.1M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s total liabilities?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s total liabilities has grown at a 44.0% compound annual growth rate (CAGR), from $10.66M to $65.96M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Eton Pharmaceuticals, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude